Display search results for ** instead (9 products)

9 Item(s)

18 Sep 2020  |  Global

Biosimilar Access to Newer Therapy Areas such as Ophthalmology to drive major growth of Biosimilar Market, 2020-2026

Outsourced manufacturing of complex third wave of biosimilars to spark new growth opportunities

The Transformational Health team at Frost & Sullivan provides critical insights into the global biosimilar industry highlighting the key growth opportunities, market revenue forecast and trends that will influence the industry with the third wave biosimilars. The global third wave biosimilars market covered in this study includes 2 major segments â...

USD 4,950.00

USD 4,455.00 save 10 %

27 Aug 2020  |  Global

Smart Labs as Key Drivers for the Digital Transformation of Diagnostic Laboratories, 2020

Robotic Automation, Internet of Things (IoT), and Artificial Intelligence (AI) Offering Growth Opportunities for Academic and Commercial Diagnostics Labs

Diagnostic academic and commercial research labs suffer from cost pressures, given the ongoing Protecting Access to Medicare Act (PAMA) regulations and reproducibility issues, and are under productivity strain. The recent COVID-19 pandemic leading to increasing test volumes and renewed focus on research and development (R&D) to drive innovation wil...

USD 3,000.00
28 Jul 2020  |  North America

National eHealth Initiatives Advancing Global Precision Medicine Market, 2018–2025

Taiwan, Estonia, and Finland Emerging as Key Markets Fueling Growth Opportunities in Precision Medicine Informatics

Precision medicine is transitioning toward wider acceptance, due to mounting payer pressures and regulatory changes that are shifting pharma businesses from prescriptive to more predictive and personalized models. Emergence of value-based reimbursement models and healthcare consumerism trends are helping move the treatment model from ‘one-size-fi...

USD 3,000.00
24 Jul 2020  |  North America

Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024

Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies

With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies,...

USD 4,950.00
09 Jul 2020  |  North America

Post-pandemic Global Healthcare Market Outlook, 2020

Stakeholders to Focus on Resource Optimization, New Growth Segments, and Cost Rationalization in a New Era of ‘Healthcare Preparedness’

Every year, the team of futurists, analysts, and consultants in Frost & Sullivan's Transformational Healthcare Group comes together to render a comprehensive analysis to predict the themes, technologies, and global forces that will define the next 12 to 18 months (future) for the healthcare industry. In light of the lessons learned from the COVID-1...

USD 4,950.00
07 Feb 2020  |  Asia Pacific

Thai Diabetes Devices Market, Forecast to 2023

The Professional Testing Segment will See a High Growth Rate of 10% in this High-cost Device Market

Diabetes is a growing global concern, with more than 425 million people suffering the world over. Thailand is no exception. It has a high prevalence of about 8%; there were an estimated 4.25 million diabetics in the country in 2018. Unfortunately, only about 56% of this population is actually diagnosed, meaning almost half of those diabetics are di...

USD 3,000.00
07 Feb 2020  |  Asia Pacific

Malaysian Diabetes Devices Market, Forecast to 2023

Service Models that Address Affordability are the Preferred Models in this Cost-sensitive Market

Diabetes is a growing concern globally, with more than 425 million people suffering the world over. Malaysia is no exception. It has a very high prevalence of about 16%; there were an estimated 3.57 million diabetics in the country in 2018. Unfortunately, only about 50% of this population is actually diagnosed, meaning half of those diabetics are d...

USD 3,000.00
06 Feb 2020  |  Asia Pacific

Philippine Diabetes Devices Market, Forecast to 2023

Universal Healthcare Coverage will Help Boost the Low Diagnosis Rate of 33% and Unlock Market Potential

Diabetes is a growing concern globally, with more than 425 million people suffering the world over. The Philippines is no exception. It has a high prevalence of diabetes, of about 6% or an estimated 3.8 million diabetics, in 2018. Unfortunately, only about 33% of this population is actually diagnosed, meaning more than two-thirds of those diabetic...

USD 3,000.00
06 Feb 2020  |  Asia Pacific

Indonesian Diabetes Devices Market, Forecast to 2023

Low Diagnosis Rate of 26% Presents Opportunities to Unlock and Tap in to a Large Market

Diabetes is a growing concern, with more than 425 million people suffering the world over. Indonesia is no exception. It has high prevalence, of about 7% or an estimated 10.48 million diabetics in the country in 2018. Unfortunately, only about 26% of this population is actually diagnosed, meaning over two-thirds of those diabetics are diagnosed onl...

USD 3,000.00

9 Item(s)